Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Vitvitsky, Victor ^a   Dayal, Sanjana ^c   Stabler, Sally ^b   Zhou, You ^a   Wang, Hong ^d   Lentz, Steven R ^c   Banerjee, Ruma ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cystathionine synthase; Cysteine; Glutathione; Homocystinuria

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CARDIOVASCULAR DISEASE; CBS GENE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE; GENE DISRUPTION; GENOTYPE; HOMEOSTASIS; HYPERHOMOCYSTEINEMIA; KIDNEY; LIVER; MALE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; TISSUE SPECIFICITY;

ANIMALS; ASCORBIC ACID; BLOTTING, WESTERN; DIET; FOLIC ACID; GLUTATHIONE; HEPATOCYTES; HOMEOSTASIS; HOMOCYSTEINE; METHIONINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATION-REDUCTION; OXIDATIVE STRESS; TERT-BUTYLHYDROPEROXIDE; TISSUE DISTRIBUTION;

EID: 3042698674     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00036.2004     Document Type: Article

References (39)

1. Arbeitman MN, Furlong EE, Imam F, Johnson E, Null BH, Baker BS, Krasnow MA, Scott MP, Davis RW, and White KP. Gene expression during the life cycle of Drosophila melanogaster. Science 297: 2270-2275, 2002.
2. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Bones C, Newcombe RG, and Lewis MJ. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 98: 1848-1852, 1998.
3. Borroz KI, Buetler TM, and Eaton DL. Modulation of gamma-glutamylcysteine synthetase large subunit mRNA expression by butylated hydroxyanisole. Toxicol Appl Pharmacol 141: 150-155, 1994.
4. Boushey CJ, Beresford SA, Omenn GS, and Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049-1057, 1995.
5. Brattström LE, Hadebo JE, and Hultberg BL. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 15: 1012-1016, 1984.
6. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler b, and Graham I. Hyperhomocyteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155, 1991.
7. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, and Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 55: 1449-1455, 1998.
8. Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, and Lentz SR. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res 88: 1203-1209, 2001.
9. Dayal S, Brown KL, Weydert CJ, Oberley LW, Arning E, Bottiglieri T, Faraci FM, and Lentz SR. Deficiency of glutathione peroxidase-I sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler Thromb Vasc Biol 22: 1996-2002, 2002.
10. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, and Loscalzo J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 106: 483-491, 2000.
11. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, and Schmidt AM. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107: 675-683, 2001.
12. Huang ZA, Yang H, Chen C, Zeng Z, and Lu SC. Inducers of gamma-glutamylcysteine synthetase and their effects on glutathione synthetase expression. Biochim Biophys Acta 1493: 48-55, 2000.
13. Huang ZZ, Li H, Cai J, Kuhlenkamp J, Kaplowitz N, and Lu SC. Changes in glutathione homeostasis during liver regeneration in the rat. Hepatology 27: 147-153, 1998.
14. Jain A, Martensson J, Mehta T, Krauss AN, Auld PA, and Meister A. Ascorbic acid prevents oxidative stress in glutathione-deficient mice: effects on lung type 2 cell lamellar bodies, lung surfactant, and skeletal muscle. Proc Natl Acad Sci USA 89: 5093-5097, 1992.
15. Kang SS, Wong PW, and Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12: 279-298, 1992.
16. Kashiwamata S and Greenberg DM. Studies on cystathionine synthase of rat liver. Properties of the highly purified enzyme. Biochim Biophys Acta 212: 488-500, 1970.
17. Lentz SR. Homocysteine and vascular dysfunction. Life Sci 61: 1205-1215, 1997.
18. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, and Faraci FM. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol Heart Circ Physiol 279: H970-H975, 2000.
19. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, and Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 98: 24-29. 1996.
20. Majors AK and Pyeritz RE. A deficiency of cysteine impairs fibrillin-1 deposition: implications for the pathogenesis of cystathionine beta-synthase deficiency. Mol Genet Metab 70: 252-260, 2000.
21. Martensson J, Han J, Griffith OW, and Meister A. Glutathione ester delays the onset of scurvy in ascorbate-deficient guinea pigs. Proc Natl Acad Sci USA 90: 317-321, 1993.
22. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 54: 1969s-1975s, 1994.
23. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conle MR, and Weir DG. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345: 149-151, 1995.
24. Mosharov E, Cranford MR, and Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 39: 13005-13011, 2000.
25. Mudd SH, Levy HL, and Skovby F. The Metabolic and Molecular Basis of Inherited Diseases. New York: McGraw-Hill, 1995.
26. Omaye ST, Turnbull JD, and Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62: 3-11, 1979.
27. Reed D, Babson J, Beatty P, Brodie A, Ellis W, and Potter D. High performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide and related thiols and disulfides. Anal Biochem 106: 55-62, 1980.
28. Refsum H, Ueland PM, Nygard O, and Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 49: 31-62, 1998.
29. Selhub J, Jacques PF, Wilson PW, Rush D, and Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270: 2693-2698, 1993.
30. Shi ZZ, Osei-Frimpong J, Kala G, Kala SV, Barrios RJ, Habib GM, Lukin DJ, Danney CM, Matzuk MM, and Lieberman MW. Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc Natl Acad Sci USA 97: 5101-5106, 2000.
31. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, and Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 81: 466-474, 1988.
32. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Finkelstein JD, Blom HJ, Thomas CM, Borm GF, Wouters MG, and Eskes TK. Maternal hyperhomocysteinemia: a risk factor for neural tube defects? Metabolism 43: 1475-1480, 1994.
33. Urata Y, Yamamoto H, Golo S, Tsushima H, Akazawa S, Yamashita S, Nagataki S, and Kondo T. Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1beta and tumor necrosis factor-alpha in mouse endothelial cells. J Biol Chem 271: 15146-15152, 1996.
34. 12 and folate. Am J Epidemiol 143: 845-859, 1996.
35. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, and Maeda N. Mice deficient in cystathionine β-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 92: 1585-1589, 1995.
36. Weiss N, Heydrick S, Zhang YY, Bierl C, Cap A, and Loscalzo J. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta synthase-deficient mice. Aterioscler Thromb Casc Biol 2: 34-41, 2001.
37. Weiss N, Zhang YY, Heydrick S, Bierl C, and Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci USA 98: 12503-12508, 2001.
38. Woo KS, Chook P, Lolin YI, Cheung AS, Chan LT, Sun YY, Sanderson JE, Metreweli C, and Celermajer DS. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96: 2542-2544, 1997.
39. Zannoni V, Lynch M, Goldstein S, and Sato P. A rapid micromethod for the determination of ascorbic acid in plasma and tissues. Biochem Med 11: 41-48, 1974.